Markets Stocks Economy Crypto Earnings Banking Energy
Home Stocks Feature
Breaking · Stocks

Regis Healthcare shares plunge 34% as aged-care funding lags costs

Regis Healthcare shares plunge 34% as aged-care funding lags costs
Stocks · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Sep 3, 2026 4 min read

Regis Healthcare, one of Australia's largest residential aged-care providers, saw its shares tumble as much as 34.6% on Tuesday, hitting a more than two-year low. The sharp sell-off came after the federal government announced its annual reset of funding for the sector, and Regis said the increase falls short of covering its rising costs.

Australia's Department of Health, Disability and Ageing raised the Australian National Aged Care Classification (AN-ACC) “starting price” to A$303.19 from A$295.64, effective October 1. The department said the change lifts average funding to about A$325 per resident per day. But for Regis, the increase of just 2.55% is not enough to keep pace with the wage growth and other input costs that are squeezing its margins.

Why the funding rate matters

The AN-ACC is the system the Australian government uses to allocate funding to residential aged-care providers. Each resident is assessed and classified into one of several categories, and the starting price is the base amount the government pays per resident per day. That rate effectively sets the bulk of the revenue an operator like Regis can earn for providing care.

For Regis, the funding rate is critical because its biggest cost is labor. Nursing wages, in particular, have been rising steadily, driven by both industry-wide shortages and government-mandated wage increases for aged-care workers. When the funding increase lags wage growth, the gap between revenue and costs narrows, putting pressure on profit margins.

The company's reaction was blunt: the 2.55% rise “still trails wage growth and other costs.” That message sent a clear signal to investors that the operating environment for aged-care providers remains tough, despite the government's attempt to boost funding.

What this means for the sector

The aged-care sector in Australia has been under intense scrutiny in recent years, with the Royal Commission into Aged Care Quality and Safety leading to a wave of reforms. Providers have been required to lift staffing levels and improve care standards, which has increased costs. At the same time, the government has been trying to balance the need for better care with the fiscal cost of funding it.

For listed aged-care operators like Regis, the funding reset is a key annual event. Investors watch it closely because it directly affects revenue and profitability. When the increase is seen as inadequate, as it was this time, the market reacts swiftly.

The broader Australian market has been mixed recently, with gains in some sectors offset by weakness in others. But the sharp drop in Regis shares was a standout move, reflecting the specific pressures facing the aged-care industry.

What it means for investors

For everyday investors, the key takeaway is that government funding decisions can have a huge impact on companies that rely on public money. Aged-care providers are heavily dependent on the AN-ACC rate, and when that rate doesn't keep up with costs, their earnings and share prices can suffer.

Regis's share price drop is a reminder that investing in regulated industries carries unique risks. While the government sets the funding, the companies still have to manage their own costs, and if those costs rise faster than the funding, profits get squeezed.

Investors should also note that the funding reset applies to the entire sector, not just Regis. Other listed aged-care providers could face similar pressures, though the impact may vary depending on their cost structures and resident mix.

Looking ahead, the market will be watching whether the government adjusts the funding formula in future resets, and whether Regis can find ways to cut costs or improve efficiency. The company's next earnings report will be closely scrutinized for signs of how the funding change is affecting its bottom line.

For now, the message from the market is clear: the aged-care funding reset has not been kind to Regis, and investors are voting with their feet.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B